Key Drivers
- Stable Profitability
- High Leverage
- Limited Liquidity
AIAI Summary
PNTG is an acquisition-led margin-expansion story—not a steady-care operator—so investors should only underwrite its premium valuation if Amedisys/UnitedHealth assets can credibly reach the targeted 18% margins by 2027–2028 while debt and cash-conversion risk remain controlled.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Stable Profitability
- •High Leverage
- •Limited Liquidity
PNTG is profitable with stable margins and improving liquidity, but high leverage, significant intangibles, and elevated valuation multiples warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Mild recovery
- •Sharp reversal
- •Key breakout
PNTG shows a mild last-month recovery but needs to hold $39.00 and reclaim $40.10 to offset the sharp pullback from $42.48.
Sharp reversal from $42.48 to $39.62 in two sessions
Sentiment & News
Key News Insights:
- •Buy Rating Upgrade
- •BlackRock Stake
- •Real Estate Expansion
Pennant Group's Buy-rating upgrade, BlackRock's sizable stake, and senior-living real-estate acquisition support a constructive outlook, though estimate-trend risks may temper near-term gains.
Positive institutional and operational catalysts could support PNTG's valuation, but earnings revisions remain a near-term risk
Similar Companies in Healthcare
Other companies in the same sector with AI ratings